Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Discovery Value Fund

Q4 2023 · 13F-HR

Discovery Value Fundholdings as filed

Filed 2024-02-07 · accession 0001750451-24-000001

$219.1M
Reported value
10
Positions
2023-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
25809K105DASHDOORDASH INC$163.0M74.4%1,648,516CommonSOLE
45826J105NTLAINTELLIA THERAPEUTICS INC$17.1M7.82%561,561CommonSOLE
92189F676SMHVANECK ETF TRUST$15.1M6.89%86,291CommonSOLE
46090E103QQQINVESCO QQQ TR$14.6M6.68%35,744CommonSOLE
67066G104NVDANVIDIA CORPORATION$3.7M1.67%7,409CommonSOLE
037833100AAPLAPPLE INC$2.8M1.27%14,498CommonSOLE
87918A105TDOCTELADOC HEALTH INC$1.5M0.67%67,639CommonSOLE
594918104MSFTMICROSOFT CORP$729,5180.33%1,940CommonSOLE
11135F101AVGOBROADCOM INC$524,6380.24%470CommonSOLE
26603R106DUOLDUOLINGO INC$26,5410.01%117CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.